期刊文献+

Serum adiponectin concentrations in patients with essential hypertension

Serum adiponectin concentrations in patients with essential hypertension
下载PDF
导出
摘要 Objective: To explore the serum levels of adiponectin in patients with essential hypertension and the relation between adiponectin and blood pressure. Methods: Forty-five cases with essential hypertension and 43 healthy control subjects have been taken fasting blood samples for measurements of plasma glucose, plasma lipids, insulin, C-peptide, thyroid hormones, TNF-α, leptin and adiponectin. Glucose tolerance was assessed by 75-g oral glucose tolerance test. Results: The concentrations of adiponectin in cases with essential hypertension were significantly lower than those in the control group (4.15 ± 1.99 vs 7.04 ± 3.13 mg/ml, P = 0.000). Pearson relation analysis showed that serum adiponectin concentrations were negatively and significantly correlated with body-mass index ( r = - 0. 274, P = 0. 038), total cholesterol (r= -0.257, P = 0.048)in control groups, while adiponectin concentrations were negatively and significantly correlated with systolic blood pressure (r = - 0.356, P = 0.016), triglyceride ( r = - 0.367, P = 0.013), tumor necrosis factor-alpha ( r = -0.298, P = 0.047) and triiodothyronine( r = -0.317, P = 0.034) in essential hypertension group. Multiple regression analysis showed that body-mass index was the independent factor to adiponectin levels, and SBP and TNF-αwere adiponectin independent factors in the essential hypertension group. Conclusion: The serum adiponectin concentrations are significant lower in patients with essential hypertension, and there is negative and significantly correlation between adiponectin and blood pressure. To explore the serum levels of adiponectin in patients with essential hypertension and the relationbetween adiponectin and blood pressure. Methods: Forty-five cases with essential hypertension and 43 healthy control sub-jects have been taken fasting blood samples for measurements of plasma glucose, plasma lipids, insulin, C-peptide, thyroidhormones, TNF-α, leptin and adiponectin. Glucose tolerance was assessed by 75-g oral glucose tolerance est. Results: Theconcentrations of adiponectin in cases with essential hypertension were significantly lower than those in the control group(4.15 ± 1.99 vs 7.04 ± 3.13 mg/ml, P = 0.000). Pearson relation analysis showed that serum adiponectin concentrationswere negatively and significantly correlated with body-mass index ( r = - 0. 274, P = 0. 038 ), total cholesterol(r = -0.257, P = 0.048)in control groups, while adiponectin concentrations were negatively and significantly correlatedwith systolic blood pressure ( r = - 0.356, P = 0.016), triglyceride ( r = - 0.367, P = 0.013), tumor necrosis factor-al-pha ( r = - 0. 298, P = 0.047) and triiodothyronine ( r = - 0.317, P = 0. 034) in essential hypertension group. Multipleregression analysis showed that body-mass index was the independent factor to adiponectin levels, and SBP and TNF-α wereadiponectin independent factors in the essential hypertension group. Conclusion: The serum adiponectin concentrations aresignificant lower in patients with essential hypertension, and there is negative and significantly correlation between adiponec-tin and blood pressure.
出处 《Journal of Medical Colleges of PLA(China)》 CAS 2004年第6期367-370,共4页 中国人民解放军军医大学学报(英文版)
关键词 HYPERTENSION ADIPONECTIN 免疫血清 己二腈浓度 原发性高血压 心血管疾病
  • 相关文献

参考文献20

  • 1[1]Scherer PE, Willians S, Fogliano M et al. A novel serum protein similar to C1q, produced exclusively in adipocytes [J]. J Biol Chem, 1995; 270(45): 2646.
  • 2[2]Nakano Y, Tobe T, Choi-Miura NH et al. Isolation and characterization of GBP28, a novel gelatin-binding protein purified from human plasma[J]. J Bio Chem (Tokyo), 1996; 120(4): 803.
  • 3[3]Arita Y, Kihara S, Ouchi N et al. Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity [ J]. Biochem Biophys Res Commun,1999; 257(1): 79.
  • 4[4]Hanley A J, Connelly PW, Harris SB et al. Adiponectin in a Native Canadian Population Experiencing Repid Epidemiological Transition [J]. Diabetes Care, 2003; 26(12): 3219.
  • 5[5]Dzielinska Z, Januszewicz A, Wiecek A et al. Decreased plasma concentration of a novel anti-inflammatory protein-adiponectin-in hypertensive men with coronary artery disease [J]. Thromb Res, 2003; 110(5 - 6): 365.
  • 6[6]Fruebis J, Tsao TS, Javorschis et al. Proteolytic cleavage product of 30-KDa adipocyc complement-related protein increases fatty acid oxidation in muscle and causes weight loss in mice [J]. Proc Nat Acad Sci USA, 2001;98(4): 2005.
  • 7[7]Tomas E, Tsao TS, Saha AK et al. Enhanced muscle fat oxidation and glucose transport by ACRP30 globular domain: acety1-CoA carboxylase inhibition and AMP-activated protein kinase activation [ J ]. Proc Natl Acad Sci USA, 2002; 99 (25): 16309.
  • 8[8]Yamauchi T, Kamon J, Mizokoshi Y et al. Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase [J]. Nat Med, 2002; 8(11): 1288.
  • 9[9]Ouchi N, Kihara S, Arita Y et al. Novel modulator for endothelial adhesion molecules: adipocyte-derived plasma protein diponectin [J]. Circulation, 1999; 100(25): 2473.
  • 10[10]Ouchi N, Kihara S, Arita Y et al. Adipocyte-derived Plasma Protein,adiponectin suppresses lipid accumulation and class A scavenger receptor expression in human monocyte-derived macrophages [ J ]. Circulation,2001; 103 (8): 1057.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部